Moderator:

• Leslie Clark, MD, Gynecologic Oncologist, University of North Carolina in Chapel Hill

Speakers:

• Róisín O’Cearbhaill, MD, Medical Oncologist, Memorial Sloan Kettering Cancer Center
• Ramez Eskander, MD, Gynecologic Oncologist, University of California San Diego

Leslie Clark, MD, presents a patient case to frame a discussion on the management of immunotherapy-related toxicities in gynecologic cancers. Róisín O’Cearbhaill, MD, and Ramez Eskander, MD, provide clinical management strategies for adverse events that gynecologic oncologists commonly encounter, such as diarrhea, rash, and hypothyroidism, as well as their approaches to situations that can be more difficult to discern, such as pneumonitis. This podcast was published in July 2022 and developed by the Society of Gynecologic Oncology for Gynecologic Oncology.

Keywords: Immunotherapy, Toxicity, Checkpoint blockade, Pembrolizumab, Endometrial cancer, Cervical cancer